Advertisement

Syncope pp 45-57 | Cite as

The Economic Impact of Syncope: Direct and Indirect Costs

  • Aalap D. Narichania
  • Mohamed H. HamdanEmail author
Chapter
  • 15 Downloads

Abstract

In this chapter, we explore the economic impact of syncope and potential strategies to attenuate the burden. Syncope is a very common problem with an estimated yearly cost greater than $10 billion USD annually in the USA alone. Direct costs include costs of health care-delivery, while indirect cost includes the impact on patient and society such as loss of productivity and earning potential. Drivers of direct cost include the high admission rate, unnecessary tests utilization, and unexplained syncope. Decreasing both direct and indirect costs is contingent on obtaining an accurate diagnosis through a standardized approach informed by the guidelines. More advanced data methods such as machine learning, point-of-care software, telemedicine, and use of non-physician providers may also help further reduce cost, and expand cost-effective state-of-the-art syncope care in areas where it is much needed.

Notes

Conflict of Interest

None.

References

  1. 1.
    Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ. 2000;320(7245):1335.CrossRefGoogle Scholar
  2. 2.
    Lamb LE, Green HC, Combs JJ, Cheeseman SA, Hammond J. Incidence of loss of consciousness in 1,980 air force personnel. Aerosp Med. 1960;31:973–88.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Chen LY, Shen WK, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Prevalence of syncope in a population aged more than 45 years. Am J Med. 2006;119(12):1088.e1081–7.Google Scholar
  4. 4.
    Alshekhlee A, Shen WK, Mackall J, Chelimsky TC. Incidence and mortality rates of syncope in the United States. Am J Med. 2009;122(2):181–8.CrossRefGoogle Scholar
  5. 5.
    Sun BC, Emond JA, Camargo CA Jr. Characteristics and admission patterns of patients presenting with syncope to U.S. emergency departments, 1992-2000. Acad Emerg Med. 2004;11(10):1029–34.PubMedGoogle Scholar
  6. 6.
    Sun BC. Quality-of-life, health service use, and costs associated with syncope. Prog Cardiovasc Dis. 2013;55(4):370–5.CrossRefGoogle Scholar
  7. 7.
    Anand V, Benditt DG, Adkisson WO, Garg S, George SA, Adabag S. Trends of hospitalizations for syncope/collapse in the United States from 2004 to 2013-an analysis of national inpatient sample. J Cardiovasc Electrophysiol. 2018;29(6):916–22.CrossRefGoogle Scholar
  8. 8.
    Joy PS, Kumar G, Olshansky B. Syncope: outcomes and conditions associated with hospitalization. Am J Med. 2017;130(6):699–706.e696.CrossRefGoogle Scholar
  9. 9.
    Kadri AN, Abuamsha H, Nusairat L, et al. Causes and predictors of 30-day readmission in patients with Syncope/collapse: a Nationwide cohort study. J Am Heart Assoc. 2018;7(18):e009746.CrossRefGoogle Scholar
  10. 10.
    Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70(5):e39–e110.CrossRefGoogle Scholar
  11. 11.
    Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883–948.CrossRefGoogle Scholar
  12. 12.
    Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668–71.CrossRefGoogle Scholar
  13. 13.
    HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. https://hcupnet.ahrq.gov.
  14. 14.
    Malasana G, Brignole M, Daccarett M, Sherwood R, Hamdan MH. The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin Electrophysiol. 2011;34(3):278–83.CrossRefGoogle Scholar
  15. 15.
    Baron-Esquivias G, Moreno SG, Martinez A, et al. Cost of diagnosis and treatment of syncope in patients admitted to a cardiology unit. Europace. 2006;8(2):122–7.CrossRefGoogle Scholar
  16. 16.
    Brignole M, Ungar A, Bartoletti A, et al. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006;8(8):644–50.CrossRefGoogle Scholar
  17. 17.
    Sanders NA, Jetter TL, Brignole M, Hamdan MH. Standardized care pathway versus conventional approach in the management of patients presenting with faint at the University of Utah. Pacing Clin Electrophysiol. 2013;36(2):152–62.CrossRefGoogle Scholar
  18. 18.
    Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2011;13(2):262–9.CrossRefGoogle Scholar
  19. 19.
    Edvardsson N, Wolff C, Tsintzos S, Rieger G, Linker NJ. Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry. Europace. 2015;17(7):1141–8.CrossRefGoogle Scholar
  20. 20.
    Ng J, Sheldon RS, Maxey C, et al. Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up. Auton Neurosci. 2019;219:42–8.CrossRefGoogle Scholar
  21. 21.
    Rafanelli C, Gostoli S, Roncuzzi R, Sassone B. Psychological correlates of vasovagal versus medically unexplained syncope. Gen Hosp Psychiatry. 2013;35(3):246–52.CrossRefGoogle Scholar
  22. 22.
    Kouakam C, Lacroix D, Klug D, Baux P, Marquie C, Kacet S. Prevalence and prognostic significance of psychiatric disorders in patients evaluated for recurrent unexplained syncope. Am J Cardiol. 2002;89(5):530–5.CrossRefGoogle Scholar
  23. 23.
    Walsh KE, Baneck T, Page RL, Brignole M, Hamdan MH. Psychogenic pseudosyncope: not always a diagnosis of exclusion. Pacing Clin Electrophysiol. 2018;41(5):480–6.CrossRefGoogle Scholar
  24. 24.
    Nume AK, Kragholm K, Carlson N, et al. Syncope and its impact on occupational accidents and employment: a Danish Nationwide retrospective cohort study. Circ Cardiovasc Qual Outcomes. 2017;10(4):e003202.CrossRefGoogle Scholar
  25. 25.
    Sorajja D, Nesbitt GC, Hodge DO, et al. Syncope while driving: clinical characteristics, causes, and prognosis. Circulation. 2009;120(11):928–34.CrossRefGoogle Scholar
  26. 26.
    Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco Syncope rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004;43(2):224–32.CrossRefGoogle Scholar
  27. 27.
    Ammirati F, Colivicchi F, Santini M. Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial - the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio). Eur Heart J. 2000;21(11):935–40.CrossRefGoogle Scholar
  28. 28.
    Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010;55(8):713–21.CrossRefGoogle Scholar
  29. 29.
    Falavigna G, Costantino G, Furlan R, Quinn JV, Ungar A, Ippoliti R. Artificial neural networks and risk stratification in emergency departments. Intern Emerg Med. 2019;14(2):291–9.CrossRefGoogle Scholar
  30. 30.
    Shen WK, Decker WW, Smars PA, et al. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation. 2004;110(24):3636–45.CrossRefGoogle Scholar
  31. 31.
    Hamdan MH, Walsh KE, Brignole M, Key J. Outreach syncope clinic managed by a nurse practitioner: outcome and cost effectiveness. J Telemed Telecare. 2017;24(8):566–71.CrossRefGoogle Scholar
  32. 32.
    Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42(3):495–501.CrossRefGoogle Scholar
  33. 33.
    Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J. 2006;27(3):351–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Cardiology, Department of Internal MedicineUniversity of Wisconsin—MadisonMadisonUSA

Personalised recommendations